Remdesivir study shows promise as coronavirus treatment
With the U.S. death toll from the coronavirus outbreak topping 60,000 this week and confirmed cases of COVID-19 in America surpassing the one million mark, the country has seized on news that the antiviral drug remdesivir is a potential treatment for the disease.
HistoryRemdesivir was first developed in the laboratories of the American biopharmaceutical company Gilead Sciences in the hopes of treating viral infections. It was tested on a number of viruses, including SARS and MERS, prior to the outbreak of Ebola in western Africa in 2014. Gilead Sciences sought to have remdesivir approved as a treatment for Ebola, and began clinical trials to establish its effectiveness.
“We’re working with the company to emphasize the necessity of speed while at the same time to understand the data,” FDA commissioner Stephen Hahn said in a Thursday interview with Bloomberg. “There will be a lot of factors that go into all the regulatory decisions. We want to look at the totality of data to make sure that remdesivir is targeted to the right patients.”
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study Shows Shorter Course of Gilead Drug as Effective Against Covid-19Gilead Sciences said its phase 3 study for the antiviral remdesivir demonstrated that patients with severe Covid-19 taking the drug over a five-day treatment had similar improvement compared with those taking the 10-day course.
Read more »
Gilead Sciences says there are 'positive data' from a study on possible Covid-19 treatment remdesivirThere's 'positive data' emerging from a study on possible Covid-19 treatment remdesivir, the maker of the investigational drug says
Read more »
Mark Zuckerberg Is Donating $13.6 Million To Study COVID-19 Spread In Bay AreaThe Facebook cofounder and wife Priscilla Chan are backing a nine-month research project with two studies aimed at helping inform policy as California looks ahead to re-open for business.
Read more »
Children, Women Just As Likely To Contract COVID-19, But Men Exhibit Worse Symptoms, Study SuggestsChildren and women are just as likely to contract COVID-19, but men exhibit worse symptoms, a study suggests
Read more »
Study: Remdesivir appears to speed recovery times in hospitalized COVID-19 patientsEarly results released from a federal study found patients who received remdesivir had a 31% faster recovery time than those who received a placebo.
Read more »